(NASDAQ: OFIX) Orthofix Medical's forecast annual revenue growth rate of 6.64% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 57.21%.
Orthofix Medical's revenue in 2026 is $818,058,000.On average, 8 Wall Street analysts forecast OFIX's revenue for 2026 to be $34,849,679,903, with the lowest OFIX revenue forecast at $33,172,634,344, and the highest OFIX revenue forecast at $36,337,835,088. On average, 7 Wall Street analysts forecast OFIX's revenue for 2027 to be $37,018,157,230, with the lowest OFIX revenue forecast at $34,993,030,669, and the highest OFIX revenue forecast at $38,811,625,786.
In 2028, OFIX is forecast to generate $38,545,912,074 in revenue, with the lowest revenue forecast at $37,033,997,093 and the highest revenue forecast at $39,678,858,318.